Immunogenicity of Diphtheria Booster Vaccination in Adolescents With Inflammatory Bowel Disease.

Łukasz Dembiński, Elżbieta Krzesiek, Beata Klincewicz, Urszula Grzybowska-Chlebowczyk, Urszula Demkow, Aleksandra Banaszkiewicz, Andrzej Radzikowski

The Pediatric infectious disease journal 2020 Mar

filter terms:

The aim of this prospective study was to assess the immunogenicity and safety of booster vaccine against diphtheria in children with inflammatory bowel disease on and without immunosuppression treatment. Immunoprotection was achieved in 93% of the children. No significant differences depending on the treatment used and no serious adverse events or flares of inflammatory bowel disease were observed.

Citation

Łukasz Dembiński, Elżbieta Krzesiek, Beata Klincewicz, Urszula Grzybowska-Chlebowczyk, Urszula Demkow, Aleksandra Banaszkiewicz, Andrzej Radzikowski. Immunogenicity of Diphtheria Booster Vaccination in Adolescents With Inflammatory Bowel Disease. The Pediatric infectious disease journal. 2020 Mar;39(3):244-246